Boeing vs. Airbus: Which Stock Offers Greater Upside Potential?

The article favors Boeing over Airbus, citing Boeing’s 2026 EPS estimate growth of 89.85% versus Airbus’ 9.09%, a lower forward P/S of 1.36x versus 1.64x, and a 2.1% one-month share gain compared with Airbus’ 2.4% decline. Boeing’s Q3 2026 commercial deliveries rose 0.6% year over year and defense shipments increased 3.1%; FAA certification of the 737-10 clears the way for deliveries, with 1,555 orders from more than 30 customers. Airbus has defense-integration opportunities and forecasts aviation-services market growth from about $209 billion in 2026 to more than $420 billion by 2045, but both companies currently carry a Zacks Rank #4 (Sell).

Analysis

The actionable distinction is execution risk, not the headline EPS-growth comparison. For Boeing, certification removes one gating item; it does not establish a sustainable production cadence or cash conversion. A slow 737-10 ramp, supplier bottlenecks, rework, or renewed quality/regulatory scrutiny could defer backlog monetization while working-capital demands persist. The key read-through is monthly deliveries and free-cash-flow conversion, not order count. Airbus is exposed to the same narrow-body contest: a credible 737-10 ramp could pressure A321neo pricing or mix at the margin, but that effect depends on Boeing delivering reliably and airlines accepting the aircraft into service.

The article’s valuation comparison is weak: forward sales multiples do not adjust for margins, cash needs, or business mix, while Boeing’s large projected EPS increase may be recovery from a depressed base rather than normalized growth. Airbus’s services-market forecast is a long-duration industry estimate, not company revenue guidance; the air-defense exercise is capability evidence, not a funded award. Neither is a near-term earnings catalyst.

Over days, certification may support sentiment; over 1–3 months, delivery cadence, regulatory updates, and cash flow matter more. Over 6–18 months, a sustained ramp could improve Boeing’s earnings quality, but another quality or supply disruption would reverse the thesis. The contrarian point: the article treats a regulatory milestone and consensus EPS rebound as proof of recovery, while the market should demand repeatable execution. No clean relative-value pair follows from these facts alone given differing business mixes and listing/currency exposure.

Key Decisions for Investors

• Do not chase BA solely on certification or the EPS-growth estimate. Consider a staged long only after evidence of a sustained 737-10 delivery ramp and improving free-cash-flow conversion; thesis is falsified by renewed production restrictions, delivery slippage, or weaker cash conversion.
• Keep AIR as a watch rather than a short: monitor A321neo delivery/pricing commentary and whether Airbus turns the defense integration demonstration into funded contracts. The services-market forecast alone does not justify a near-term position.
• Treat the BA-versus-AIR valuation case as unproven until comparing normalized margins, free cash flow, and net debt/cash on consistent periods. Verify those metrics and production-rate constraints before sizing either exposure.
• Near-term catalyst checklist: monthly Boeing deliveries, supplier/quality disclosures, FAA actions, and quarterly free cash flow. A sustained ramp supports the recovery case; renewed regulatory intervention or worsening cash burn invalidates it.